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This blinded, cross-sectional study by Di Pasquale et al. 2 describes nerve ultrasound findings at noncompressible sites in the median, ulnar, and peroneal nerves in 19 patients with CIDP compared to controls. The authors examined the relationship between both total cross-sectional nerve area and enlargement of individual nerve fascicles and assessed electrodiagnostic measures. They also correlate abnormal ultrasound segments with clinical measures of strength and disability. Consistent with prior studies, the primary findings were that (1) ultrasound is sensitive and specific for detecting abnormality in CIDP, although the number of segments with ultrasound abnormalities was highly variable; (2) abnormal ultrasound segments were associated more frequently with demyelinating than with axonal electrophysiology; and (3) abnormality within a nerve segment was correlated with longer disease duration, lower Medical Research Council sumscore, higher Inflammatory Neuropathy Cause and Treatment disability score, and progressive disease.
While providing a substantive contribution to the literature, this study also had several limitations. Eighteen of 19 patients had already undergone treatment for CIDP. Effects of these therapies on nerve morphology remain unknown. 3 Additionally, the study included only ultrasound of distal nerve segments and measured nerve areas. Proximal segments and nerve vascularity and echogenicity may also be abnormal in CIDP. 1 To further elucidate ultrasound's role in the diagnosis and management of CIDP, large-scale, multimeasure prospective, longitudinal studies in treatment-naive patients are needed.
